New York Regulator Initiates Clinical Study on Medicinal Cannabis for Inflammatory Bowel Disease

New York Launches Observational Study on Medicinal Cannabis for IBD

The New York State Office of Cannabis Management (OCM) has announced a new clinical study to investigate the effects of cannabidiol (CBD) and tetrahydrocannabinol (THC) on patients living with inflammatory bowel disease (IBD)….